retatrutide clinical benefits Explained: Benefits, Mechanism & Insights Retatrutide (“reta”) is an experimental

Do not inject through clothing , and avoid rubbing the injection site vigorously afterward, which can increase irritation

Rotate injection sites to prevent tissue irritation

Retrieved from Foretz, M., Guigas, B., & Viollet, B

95% CI, 0.72 1.11

When switching from: Once-daily insulin glargine 300 units/mL to once-daily SEMGLEE (100 units/mL), the recommended starting SEMGLEE dosage is 80% of the insulin glargine 300 units/mL dosage that is being discontinued

If you have severe or intolerable side effects such as nausea, vomiting, diarrhea, constipation, worsening of fatigue, and dizziness, your healthcare provider will pause the medication for a few weeks and keep you on the previous tolerable dose